{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:16:20Z","timestamp":1762298180009},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12865-014-0056-x","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T17:20:57Z","timestamp":1419960057000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Vibrio cholerae ghosts (VCG) exert immunomodulatory effect on dendritic cells for enhanced antigen presentation and induction of protective immunity"],"prefix":"10.1186","volume":"15","author":[{"given":"Francis O","family":"Eko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanti","family":"Mania-Pramanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"Pais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M N","family":"Okenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arieian","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Ibegbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raedeen","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn M","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph U","family":"Igietseme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,31]]},"reference":[{"key":"56_CR1","first-page":"3","volume-title":"Chlamydial Infections","author":"J Schachter","year":"1998","unstructured":"Schachter J, Grayston JT: Epidemiology of Human Chlamydial Infections. Chlamydial Infections. Edited by: Stephens RS, Byrne GI, Christiansen G, Clarke IN, Grayston JT, Rank RG, Ridgway GL, Saikku P, Schachter J, Stamm WE. 1998, Berkeley, San Francisco, CA, 3-10."},{"key":"56_CR2","doi-asserted-by":"publisher","first-page":"S519","DOI":"10.1016\/S0002-8703(99)70291-7","volume":"138","author":"RC Brunham","year":"1999","unstructured":"Brunham RC, Zhang DJ: Transgene as vaccine for Chlamydia. Am Heart J. 1999, 138: S519-S522. 10.1016\/S0002-8703(99)70291-7.","journal-title":"Am Heart J"},{"issue":"11","key":"56_CR3","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1586\/erv.11.139","volume":"10","author":"J Igietseme","year":"2011","unstructured":"Igietseme J, Eko F, Black C: Chlamydia vaccines: recent developments and the role of adjuvants in future formulations. Expert Rev Vaccines. 2011, 10 (11): 1585-1596. 10.1586\/erv.11.139.","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 1","key":"56_CR4","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1086\/518141","volume":"45","author":"MM Levine","year":"2007","unstructured":"Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC: Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin Infect Dis. 2007, 45 (Suppl 1): S24-28. 10.1086\/518141.","journal-title":"Clin Infect Dis"},{"key":"56_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/0264-410X(92)90324-D","volume":"10","author":"J Holmgren","year":"1992","unstructured":"Holmgren J, Svennerholm A-M, Jertborn M, Clemens J, Sack D, Salenstedt R, Wigzell H: An oral B subunit:whole cell vaccine against cholera. Vaccine. 1992, 10: 911-914. 10.1016\/0264-410X(92)90324-D.","journal-title":"Vaccine"},{"issue":"8","key":"56_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1586\/14760584.2013.814862","volume":"12","author":"NG Martin","year":"2013","unstructured":"Martin NG, Snape MD: A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?. Expert Rev Vaccines. 2013, 12 (8): 837-858. 10.1586\/14760584.2013.814862.","journal-title":"Expert Rev Vaccines"},{"key":"56_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.micinf.2013.11.009","volume":"16","author":"C Cheng","year":"2013","unstructured":"Cheng C, Pal S, Tifrea D, Jia Z, de la Maza LM: A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge. Microbes Infect. 2013, 16: 244-252. 10.1016\/j.micinf.2013.11.009.","journal-title":"Microbes Infect"},{"issue":"3","key":"56_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","volume":"32","author":"RK Gupta","year":"1998","unstructured":"Gupta RK: Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev. 1998, 32 (3): 155-172. 10.1016\/S0169-409X(98)00008-8.","journal-title":"Adv Drug Deliv Rev"},{"issue":"Pt 7","key":"56_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1099\/jmm.0.038943-0","volume":"61","author":"M Kool","year":"2012","unstructured":"Kool M, Fierens K, Lambrecht BN: Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol. 2012, 61 (Pt 7): 927-934. 10.1099\/jmm.0.038943-0.","journal-title":"J Med Microbiol"},{"key":"56_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0168-1656(00)00315-1","volume":"83","author":"FO Eko","year":"2000","unstructured":"Eko FO, Mayr UB, Attridge SR, Lubitz W: Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. J Biotechnol. 2000, 83: 115-123. 10.1016\/S0168-1656(00)00315-1.","journal-title":"J Biotechnol"},{"issue":"1\u20133","key":"56_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0168-1656(95)00123-9","volume":"44","author":"MP Szostak","year":"1996","unstructured":"Szostak MP, Hensel A, Eko FO, Klein R, Auer T, Mader H, Haslberger A, Bunka S, Wanner G, Lubitz W: Bacterial ghosts: non-living candidate vaccines. J Biotechnol. 1996, 44 (1\u20133): 161-170. 10.1016\/0168-1656(95)00123-9.","journal-title":"J Biotechnol"},{"key":"56_CR12","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0264-410X(02)00677-1","volume":"21","author":"F Eko","year":"2003","unstructured":"Eko F, Lubitz W, McMillan L, Ramey K, Moore T, Ananaba GA, Lyn D, Black CM, Igietseme JU: Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine. 2003, 21: 1694-1703. 10.1016\/S0264-410X(02)00677-1.","journal-title":"Vaccine"},{"issue":"5","key":"56_CR13","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.4049\/jimmunol.173.5.3375","volume":"173","author":"FO Eko","year":"2004","unstructured":"Eko FO, He Q, Brown T, McMillan L, Ifere GO, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Igietseme JU: A novel recombinant multisubunit vaccine against Chlamydia. J Immunol. 2004, 173 (5): 3375-3382. 10.4049\/jimmunol.173.5.3375.","journal-title":"J Immunol"},{"issue":"6673","key":"56_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature. 1998, 392 (6673): 245-10.1038\/32588.","journal-title":"Nature"},{"issue":"4","key":"56_CR15","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.4049\/jimmunol.164.8.4212","volume":"164","author":"JU Igietseme","year":"2000","unstructured":"Igietseme JU, Ananaba GA, Bolier J, Bowers S, Moore T, Belay T, Eko FO, Lyn D, Black CM: Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for enhanced specific Th1 induction: potential for cellular vaccine development. J Immunol. 2000, 164 (4): 4212-4219. 10.4049\/jimmunol.164.8.4212.","journal-title":"J Immunol"},{"key":"56_CR16","first-page":"1320","volume":"56","author":"KH Ramsey","year":"1988","unstructured":"Ramsey KH, Soderberg LSF, Rank RG: Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. InfectImmun. 1988, 56: 1320-1325.","journal-title":"InfectImmun"},{"key":"56_CR17","doi-asserted-by":"crossref","unstructured":"Inaba K, Swiggard WJ, Steinman RM, Romani N, Schuler G: Isolation of dendritic cells.Curr Protoc Immunol 2001, Chapter 3: Section 1: Unit 3 7,","DOI":"10.1002\/0471142735.im0307s25"},{"key":"56_CR18","unstructured":"MacKay VLM: Immortalized Dendritic Cells. Patent US, 1997, No. 5,648,219; 1997"},{"issue":"6","key":"56_CR19","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1128\/IAI.01584-07","volume":"76","author":"X Jiang","year":"2008","unstructured":"Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC: Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun. 2008, 76 (6): 2392-2401. 10.1128\/IAI.01584-07.","journal-title":"Infect Immun"},{"issue":"7","key":"56_CR20","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.vaccine.2010.12.024","volume":"29","author":"F Eko","year":"2011","unstructured":"Eko F, Ekong E, Okenu D, He Q, Ananaba G, Black C, Igietseme J: Induction of immune memory by a multisubunit chlamydial vaccine. Vaccine. 2011, 29 (7): 1472-1480. 10.1016\/j.vaccine.2010.12.024.","journal-title":"Vaccine"},{"key":"56_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1574-695X.2006.00165.x","volume":"49","author":"L Macmillan","year":"2007","unstructured":"Macmillan L, Ifere G, He Q, Igietseme J, Kellar K, Okenu D, Eko F: A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. FEMS Immunol Med Microbiol. 2007, 49: 46-55. 10.1111\/j.1574-695X.2006.00165.x.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"27","key":"56_CR22","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/j.vaccine.2004.11.078","volume":"23","author":"W Jechlinger","year":"2005","unstructured":"Jechlinger W, Haller C, Resch S, Hofmann A, Szostak MP, Lubitz W: Comparative immunogenicity of the Hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine. 2005, 23 (27): 3609-10.1016\/j.vaccine.2004.11.078.","journal-title":"Vaccine"},{"issue":"7","key":"56_CR23","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4049\/jimmunol.158.7.3344","volume":"158","author":"LL Perry","year":"1997","unstructured":"Perry LL, Feilzer K, Caldwell HD: Immunity to Chlamydia trachomatis is mediated by T helper 1 Cells through IFN-gamma-dependent and -independent pathways. J Immunol. 1997, 158 (7): 3344-3352.","journal-title":"J Immunol"},{"key":"56_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/ACI.0b013e32833239a9","volume":"6","author":"J Allam","year":"2009","unstructured":"Allam J, Bieber T, Novak N: Dendritic cells as potential targets for mucosal immunotherapy. Curr Opin Allergy Clin Immunol. 2009, 6: 554-557. 10.1097\/ACI.0b013e32833239a9.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"56_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.smim.2011.01.004","volume":"23","author":"H Ueno","year":"2011","unstructured":"Ueno H, Klechevsky E, Schmitt N, Ni L, Flamar AL, Zurawski S, Zurawski G, Palucka K, Banchereau J, Oh S: Targeting human dendritic cell subsets for improved vaccines. Semin Immunol. 2011, 23 (1): 21-27. 10.1016\/j.smim.2011.01.004.","journal-title":"Semin Immunol"},{"issue":"3\u20134","key":"56_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jbiotec.2011.03.022","volume":"153","author":"P Kudela","year":"2011","unstructured":"Kudela P, Koller V, Mayr U, Nepp J, Kudela P, Koller V, Mayr U, Nepp J, Lubitz W, Barisani-Asenbauer T: Bacterial ghosts as antigen and drug delivery system for ocular surface diseases: effective internalization of bacterial ghosts by human conjunctival epithelial cells. J Biotechnol. 2011, 153 (3\u20134): 167-175. 10.1016\/j.jbiotec.2011.03.022.","journal-title":"J Biotechnol"},{"key":"56_CR27","first-page":"125643","volume":"2013","author":"DY Chen","year":"2013","unstructured":"Chen DY, Song PS, Hong JS, Chu CL, Pan IH, Chen YM, Lin CH, Lin SH, Lin CC: Dextromethorphan inhibits activations and functions in dendritic cells. Clin Dev Immunol. 2013, 2013: 125643-","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"56_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1128\/IAI.70.3.1097-1105.2002","volume":"70","author":"J Shaw","year":"2002","unstructured":"Shaw J, Grund V, Durling L, Crane D, Caldwell H: Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun. 2002, 70 (3): 1097-1105. 10.1128\/IAI.70.3.1097-1105.2002.","journal-title":"Infect Immun"},{"issue":"2","key":"56_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1574-695X.2008.00493.x","volume":"55","author":"EE Ekong","year":"2009","unstructured":"Ekong EE, Okenu D, Mania-Pramanik J, He Q, Igietseme J, Ananaba G, Lyn D, Black C, Eko F: A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin. FEMS Immunol & Med Microbiol. 2009, 55 (2): 280-291. 10.1111\/j.1574-695X.2008.00493.x.","journal-title":"FEMS Immunol & Med Microbiol"},{"key":"56_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000058750","volume":"74","author":"R Kitchens","year":"2000","unstructured":"Kitchens R: Role of CD14 in cellular recognition of bacterial lipopolysaccharides Chem Immunol. Chem Immunol Allergy. 2000, 74: 61-82. 10.1159\/000058750.","journal-title":"Chem Immunol Allergy"},{"key":"56_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000058751","volume":"74","author":"R Tapping","year":"2000","unstructured":"Tapping R, Tobias P: Soluble CD14-mediated cellular responses to lipopolysaccharide. Chem Immunol Allergy. 2000, 74: 108-121. 10.1159\/000058751.","journal-title":"Chem Immunol Allergy"},{"issue":"1\u20132","key":"56_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0168-1656(00)00298-4","volume":"83","author":"AG Haslberger","year":"2000","unstructured":"Haslberger AG, Kohl G, Felnerova D, Mayr UB, Furst-Ladani S, Lubitz W: Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. J Biotechnol. 2000, 83 (1\u20132): 57-66. 10.1016\/S0168-1656(00)00298-4.","journal-title":"J Biotechnol"},{"issue":"25\u201326","key":"56_CR33","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1016\/S0264-410X(03)00388-8","volume":"21","author":"FO Eko","year":"2003","unstructured":"Eko FO, Schukovskaya T, Lotzmanova EY, Firstova VV, Emalyanova NV, Klueva SN, Kravtzov AL, Livanova LF, Kutyrev VV, Igietseme JU, Lubitz W: Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. Vaccine. 2003, 21 (25\u201326): 3663-3674. 10.1016\/S0264-410X(03)00388-8.","journal-title":"Vaccine"},{"issue":"2","key":"56_CR34","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003, 3 (2): 1474-1733. 10.1038\/nri1001.","journal-title":"Nat Rev Immunol"},{"key":"56_CR35","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.67.4.1606-1613.1999","volume":"67","author":"D Zhang","year":"1999","unstructured":"Zhang D, Yang X, Lu H, Zhong G, Brunham RC: Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocytemacrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation. Infect Immun. 1999, 67: 1606-1613.","journal-title":"Infect Immun"},{"issue":"7","key":"56_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1099\/jmm.0.05093-0","volume":"52","author":"D Longbottom","year":"2003","unstructured":"Longbottom D: Chlamydial vaccine development. J Med Microbiol. 2003, 52 (7): 537-540. 10.1099\/jmm.0.05093-0.","journal-title":"J Med Microbiol"},{"key":"56_CR37","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1128\/IAI.70.6.2741-2751.2002","volume":"70","author":"RP Morrison","year":"2002","unstructured":"Morrison RP, Caldwell HD: Immunity to murine chlamydial genital infection. Infect Immun. 2002, 70: 2741-2751. 10.1128\/IAI.70.6.2741-2751.2002.","journal-title":"Infect Immun"},{"issue":"8","key":"56_CR38","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","volume":"180","author":"A Seubert","year":"2008","unstructured":"Seubert A, Monac IE, Pizza M, O\u2019Hagan DAW: The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol. 2008, 180 (8): 5402-5412. 10.4049\/jimmunol.180.8.5402.","journal-title":"J Immunol"},{"issue":"2","key":"56_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/01.cji.0000154246.89630.6f","volume":"28","author":"P Kudela","year":"2005","unstructured":"Kudela P, Paukner S, Mayr U, Cholujova D, Schwarczova Z, Sedlak J, Bizik J, Lubitz W: Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic. J Immunother. 2005, 28 (2): 136-143. 10.1097\/01.cji.0000154246.89630.6f.","journal-title":"J Immunother"},{"issue":"2","key":"56_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0264-410X(96)00141-7","volume":"15","author":"HJ Mader","year":"1997","unstructured":"Mader HJ, Szostak MP, Hensel A, Lubitz W, Haslberger AG: Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines. Vaccine. 1997, 15 (2): 195-202. 10.1016\/S0264-410X(96)00141-7.","journal-title":"Vaccine"},{"key":"56_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","volume":"335","author":"J Clemens","year":"1990","unstructured":"Clemens J, Sack D, Harris VL F, Chakraborty J, Ahmed F, Rao M, Yunus M, Huda S, Stanton B, Kay B: Field trial of oral cholera vaccines in Bangladesh: results from three year follow-up. Lancet. 1990, 335: 270-273. 10.1016\/0140-6736(90)90080-O.","journal-title":"Lancet"},{"issue":"6","key":"56_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","volume":"25","author":"DD Anh","year":"2007","unstructured":"Anh DD, Canh DG, Lopez AL, Thiem VD, Long PT, Son NH, Deen J, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, Holmgren J, Clemens J: Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine. 2007, 25 (6): 1149-1155. 10.1016\/j.vaccine.2006.09.049.","journal-title":"Vaccine"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-014-0056-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-014-0056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-014-0056-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-014-0056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T06:21:06Z","timestamp":1690784466000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-014-0056-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1186\/s12865-014-0056-x","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"3 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"584"}}